(FSTA) Fidelity MSCI Consumer - Ratings and Ratios
Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US3160923039 • Consumer Defensive
FSTA: Food, Beverages, Tobacco, Household, Personal, Care
The Fidelity® MSCI Consumer Staples Index ETF (FSTA) is designed to track the performance of the MSCI USA IMI Consumer Staples 25/50 Index, focusing on the U.S. consumer staples sector. The fund allocates at least 80% of its assets to securities within this index, which includes companies across various consumer staple sub-industries such as food, beverages, household products, and personal care. The index employs a capping methodology, limiting any single issuer to a 25% weight and the aggregate of all issuers exceeding 5% to a 50% weight, which helps mitigate concentration risk while maintaining sector exposure.
As a non-diversified fund, FSTA may concentrate its investments in a smaller number of securities compared to diversified funds, which can lead to higher volatility but also allows for targeted sector exposure. The funds expense ratio is a key consideration for long-term investors, as lower fees can compound into higher returns over time. With an AUM of approximately $1.27 billion, FSTA offers sufficient liquidity for investors seeking to allocate to the consumer staples sector.
Investors should note that FSTA does not necessarily hold all the securities in its underlying index, which allows for some flexibility in portfolio construction. This approach can help optimize tracking efficiency and reduce transaction costs. The funds performance will closely mirror the MSCI USA IMI Consumer Staples 25/50 Index, making it a straightforward way to gain exposure to the U.S. consumer staples market without the need for individual stock selection.
For fund managers and investors evaluating FSTA, it’s important to consider the sector-specific risks, such as the impact of changing consumer preferences, supply chain disruptions, and regulatory changes. Additionally, the funds lack of diversification across multiple sectors means it will be more sensitive to sector-specific downturns or outperformance. As with any ETF, evaluating the underlying index methodology, expense structure, and tracking history is essential for making an informed investment decision.
Additional Sources for FSTA ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
FSTA ETF Overview
Market Cap in USD | 1,300m |
Category | Consumer Defensive |
TER | 0.08% |
IPO / Inception | 2013-10-21 |
FSTA ETF Ratings
Growth 5y | 78.6% |
Fundamental | - |
Dividend | 51.0% |
Rel. Strength Industry | -0.97 |
Analysts | - |
Fair Price Momentum | 51.38 USD |
Fair Price DCF | - |
FSTA Dividends
Dividend Yield 12m | 2.25% |
Yield on Cost 5y | 4.02% |
Annual Growth 5y | 2.07% |
Payout Consistency | 90.4% |
FSTA Growth Ratios
Growth Correlation 3m | 52.7% |
Growth Correlation 12m | 84.5% |
Growth Correlation 5y | 92.4% |
CAGR 5y | 12.36% |
CAGR/Max DD 5y | 0.75 |
Sharpe Ratio 12m | 0.33 |
Alpha | 1.67 |
Beta | 0.33 |
Volatility | 15.66% |
Current Volume | 169.2k |
Average Volume 20d | 149.9k |
As of March 14, 2025, the stock is trading at USD 49.55 with a total of 169,211 shares traded.
Over the past week, the price has changed by -4.60%, over one month by -5.26%, over three months by -3.61% and over the past year by +7.19%.
Yes. Based on ValueRay Analyses, Fidelity MSCI Consumer (NYSE ARCA:FSTA) is currently (March 2025) a good stock to buy. It has a ValueRay Growth Rating of 78.58 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of FSTA as of March 2025 is 51.38. This means that FSTA is currently overvalued and has a potential downside of 3.69%.
Fidelity MSCI Consumer has no consensus analysts rating.
According to ValueRays Forecast Model, FSTA Fidelity MSCI Consumer will be worth about 55.9 in March 2026. The stock is currently trading at 49.55. This means that the stock has a potential upside of +12.73%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 55.9 | 12.7% |